![Eric Keller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Eric Keller is the founder of Response Pharmaceuticals, Inc., founded in 2020, holding the title of Co-Chairman & Chief Executive Officer since 2020.
Mr. Keller currently holds the position of President & Director at Noveome Biotherapeutics, Inc. since 2022.
Aktive Positionen von Eric Keller
| Unternehmen | Position | Beginn |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Präsident | 16.11.2022 |
Response Pharmaceuticals, Inc.
 Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Vorstandsvorsitzender | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Health Technology |
Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Health Technology |
